Related Experiment Video

Updated: Aug 16, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.7K

Correction to "2-Formylpyridyl Ureas as Highly Selective Reversible-Covalent Inhibitors of Fibroblast Growth Factor

Thomas Knoepfel, Pascal Furet, Robert Mah

    ACS Medicinal Chemistry Letters
    |November 20, 2020
    PubMed

    Abstract:

    [This corrects the article DOI: 10.1021/acsmedchemlett.7b00485.].

    More Related Videos

    Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library
    07:32

    Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library

    Published on: September 30, 2019

    8.0K
    An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use
    10:33

    An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use

    Published on: May 24, 2024

    1.2K

    Related Experiment Videos

    Last Updated: Aug 16, 2026

    Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
    10:33

    Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

    Published on: October 26, 2015

    11.7K
    Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library
    07:32

    Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library

    Published on: September 30, 2019

    8.0K
    An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use
    10:33

    An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use

    Published on: May 24, 2024

    1.2K

    Related Concept Videos

    Covalently Linked Protein Regulators02:04

    Covalently Linked Protein Regulators

    Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
    These groups modify specific amino acids in a protein.
    Transducer Mechanism: Enzyme-Linked Receptors01:27

    Transducer Mechanism: Enzyme-Linked Receptors

    Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
    Major types that are helpful drug targets include:

    Articles linked to this work by shared authors, journal, and citation graph.

    A 24-Day MicroCycle Journey to Interleukin-17 Inhibitors: From Library Design to Central Core Prioritization and Capping Group Identification.

    ChemMedChem·2026

    Cell-type-focused compound screen in human organoids reveals CK1 inhibition protects cone photoreceptors from death.

    Neuron·2026

    Discovery of Clinical Candidate IAG933, a Potent YAP-TEAD PPI Disrupter.

    Journal of medicinal chemistry·2026

    A duo of fungi and complex and dynamic bacterial community networks contribute to shape the Ascophyllum nodosum holobiont.

    Environmental microbiome·2025

    Fragment-based discovery enables direct targeting of the melanoma oncogene MITF.

    Nature communications·2025

    Harnessing Glutamine-117 Plasticity toward Structure-Based Identification of Triazole IL-17 Inhibitors.

    Journal of medicinal chemistry·2025

    Understanding the Photodynamic Behavior of Red Emitting Re(I)dipyrrinates in Triple-Negative Breast Cancer Cells.

    ACS medicinal chemistry letters·2026

    Novel 1H-Indole-3-carboxamide Derivatives as CDK4 Inhibitors for Treating Cancer.

    ACS medicinal chemistry letters·2026

    Targeted Degradation of CDK2: A New Strategy for Overcoming Cyclin E‑Driven Cancers.

    ACS medicinal chemistry letters·2026

    Synthetic Diastereomers of the Fungal Cycloheptapeptide Paraisariamide A Retain Ternatin-Like Biological Activity.

    ACS medicinal chemistry letters·2026

    Novel Heterocyclic Compounds for Treating HIV Infection.

    ACS medicinal chemistry letters·2026

    Novel 6,5-Bicyclic Compounds as 5‑HT2A Receptor Agonists for Treating Depression, Anxiety, Substance Abuse, and Headaches.

    ACS medicinal chemistry letters·2026

    Gallic Acid-Rich Ephedra alata: Integrated Phytochemical Profiling, Aromatase Docking, and Optimized Extraction via Box-Behnken Design.

    Chemistry & biodiversity·2026

    Discovery of Virulence Attenuator of Chromobacterium violaceum CV026 From Marine-Derived Fungus Aspergillus ochraceus LSD-13 by Inhibiting Quorum Sensing and Destroying Biofilm.

    Chemistry & biodiversity·2026

    Study on Synthesis, Antiproliferative Properties, Immunomodulatory Effects, and Anti-Breast Cancer Activity of New Δ2-Pyrazoline-1H-1,2,3-Triazole Derivatives.

    Chemistry & biodiversity·2026

    Development and Characterization of a Topical Spray Containing Channa striata and Anredera cordifolia Extracts for Wound Healing: In Vivo Evaluation in Mices.

    Drug development and industrial pharmacy·2026

    Discovery of 4-aminochalcone-based dual α-glucosidase and aldose reductase inhibitors: in vitro, in vivo, and in silico studies.

    RSC advances·2026

    Synthesis, characterization, docking and in vitro evaluation of new pyrazole-carboxylate derivatives as antibacterial, anticancer and anti-inflammatory agents.

    RSC advances·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us